GILD: Gilead Sciences Inc insider trading, 5% holders and institutional ownership
From public SEC filings: open-market insider purchases and sales (Form 4, last 180 days), holders of 5% or more (Schedules 13D and 13G) and institutional ownership (Form 13F). Insider and 5% data delayed 48 hours.
Insider trading
0 open-market buys totaling - and 4 sales totaling $3.16M in the last 180 days.
Insider sales
| Trade date | Insider | Role | Value | 10b5-1 plan |
|---|---|---|---|---|
| 2026-10-15 | Mercier Johanna | Officer | $469K | yes |
| 2026-10-15 | Dickinson Andrew D | CFO | $469K | yes |
| 2026-10-01 | O'Day Daniel Patrick | CEO | $1.77M | yes |
| 2026-10-01 | O'Day Daniel Patrick | CEO | $446K | yes |
Institutional ownership (Q2 2026)
2,297 institutions reported holding $134.53B of Gilead Sciences Inc on Form 13F (2,331 the quarter before). 128 opened a new position and 165 sold out. Shares held by institutions: +2%.
| Largest holders | Shares | Value |
|---|---|---|
| BlackRock, Inc. | 121,844,108 | $15.39B |
| VANGUARD CAPITAL MANAGEMENT LLC | 81,091,734 | $10.25B |
| FMR LLC | 66,870,816 | $8.45B |
| STATE STREET CORP | 61,216,552 | $7.73B |
| Capital World Investors | 40,988,975 | $5.18B |
| Invesco Ltd. | 39,819,151 | $5.03B |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 35,316,168 | $4.46B |
| GEODE CAPITAL MANAGEMENT, LLC | 30,065,642 | $3.80B |
| MORGAN STANLEY | 24,004,354 | $3.03B |
| Dodge & Cox | 23,677,567 | $2.99B |
Get new insider and activist filings the morning after: daily alerts. Not investment advice.